WOONSOCKET, R.I., May 10, 2017 /PRNewswire/ -- Shareholders of CVS Health (NYSE: CVS) re-elected all eleven standing members of the CVS Health Board of Directors and voted to elect the Honorable Mary L. Schapiro, the 29th chairman of the U.S. Securities and Exchange Commission (SEC), as a new member of the company's Board today during the company's Annual Meeting of Stockholders.
The standing CVS Health directors who were re-elected to the Board include: Richard M. Bracken; C. David Brown II; Alecia A. DeCoudreaux; David W. Dorman (Chairman); Nancy-Ann M. DeParle; Anne M. Finucane; Larry J. Merlo; Jean-Pierre Millon; Richard J. Swift; William G. Weldon; and Tony L. White.
In welcoming Schapiro to the corporate board, Chairman David W. Dorman commented on the unique expertise she would bring to CVS Health.
"We welcome Mary's extraordinary record of leadership and unmatched commitment to investor protection and sound financial policy," said David W. Dorman, Chairman of the Board, CVS Health. "Her extensive knowledge of the U.S. financial and regulatory landscape and understanding of corporate governance and complex financial infrastructure will be of great value to the board and benefit to CVS Health and its stockholders."
Schapiro currently serves as the Vice Chair of Promontory Advisory Board, part of Promontory Financial Group, a leading strategy, risk management and regulatory compliance firm that was acquired by IBM Corporation in November 2016.
From January 2009 through December 2012, Ms. Schapiro was Chairman of the U.S. Securities and Exchange Commission, becoming the first woman to serve as that agency's Chairman. During her four years leading the agency which followed the 2008 financial crisis, the SEC pursued one of the busiest rulemaking agendas in its history. Additionally, the agency executed a comprehensive restructuring program to improve protections for investors.
Before becoming SEC chairman, Ms. Schapiro served as CEO of the Financial Industry Regulatory Authority, the largest nongovernmental regulator of securities firms. Earlier, she was Commodity Futures Trading Commission (CFTC) chairman and a commissioner of the SEC. She began her career at the CFTC, serving first as a trial attorney and later as counsel and executive assistant to the chairman.
In addition to being the first woman to serve as SEC chairman, Ms. Schapiro is the only person to have served as chairman of both the SEC and the CFTC.
Ms. Schapiro is also a director of General Electric Company and the London Stock Exchange Group. A graduate of Franklin and Marshall College, she received a JD from George Washington University.
About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.
Joe Goode, 401-770-9820
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cvs-health-stockholders-elect-former-sec-chairman-mary-l-schapiro-as-new-director-at-annual-meeting-300455224.html
SOURCE CVS Health